Stress-specific signatures: expression profiling of p53 wild-type and -null human cells

被引:98
|
作者
Amundson, SA
Do, KT
Vinikoor, L
Koch-Paiz, CA
Bittner, ML
Trent, JM
Meltzer, P
Fornace, AJ
机构
[1] NCI, Gene Response Sect, Canc Res Ctr, Bethesda, MD 20892 USA
[2] NHGRI, Canc Genet Branch, Bethesda, MD 20892 USA
关键词
cDNA microarray; DNA damage; heavy metals; p53;
D O I
10.1038/sj.onc.1208653
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gene expression responses of human cell lines exposed to a diverse set of stress agents were compared by cDNA microarray hybridization. The B-lymphoblastoid cell line TK6 (p53 wild- type) and its p53-null derivative, NH32, were treated in parallel to facilitate investigation of p53-dependent responses. RNA was extracted 4 h after the beginning of treatment when no notable decrease in cell viability was evident in the cultures. Gene expression signatures were defined that discriminated between four broad general mechanisms of stress agents: Non-DNA-damaging stresses ( heat shock, osmotic shock, and 12-O-tetradecanoylphorbol 13-acetate), agents causing mainly oxidative stress ( arsenite and hydrogen peroxide), ionizing radiations ( neutron and gamma-ray exposures), and other DNA-damaging agents ( ultraviolet radiation, methyl methanesulfonate, adriamycin, camptothecin, and cis-Platinum( II) diammine dichloride ( cisplatin)). Within this data set, non-DNA-damaging stresses could be discriminated from all DNA-damaging stresses, and profiles for individual agents were also defined. While DNA-damaging stresses showed a strong p53-dependent element in their responses, no discernible p53-dependent responses were triggered by the non-DNA-damaging stresses. A set of 16 genes did exhibit a robust p53-dependent pattern of induction in response to all nine DNA-damaging agents, however.
引用
收藏
页码:4572 / 4579
页数:8
相关论文
共 50 条
  • [21] Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53
    Ramos, YFM
    Stad, R
    Attema, J
    Peltenburg, LTC
    van der Eb, AJ
    Jochemsen, AG
    CANCER RESEARCH, 2001, 61 (05) : 1839 - 1842
  • [22] Targeting gene expression to tumor cells with loss of wild-type p53 function
    Zhu, JD
    Gao, BM
    Zhao, JQ
    Balmain, A
    CANCER GENE THERAPY, 2000, 7 (01) : 4 - 12
  • [23] COTRANSLATION OF ACTIVATED MUTANT P53 WITH WILD-TYPE DRIVES THE WILD-TYPE P53 PROTEIN INTO THE MUTANT CONFORMATION
    MILNER, J
    MEDCALF, EA
    CELL, 1991, 65 (05) : 765 - 774
  • [24] Molecular basis for the accelerated senescence response to doxorubicin in p53 wild-type and p53 null/mutant breast tumor cells.
    Di, Xu
    Gewirtz, David
    CANCER RESEARCH, 2009, 69
  • [25] Wild-type p53 reduces radiation hypermutability in p53-mutated human lymphoblast cells
    Zhang, Qinming
    Liu, Yunfeng
    Zhou, Juntling
    Chen, Weihong
    Zhang, Ying
    Liber, Howard L.
    MUTAGENESIS, 2007, 22 (05) : 329 - 334
  • [26] Restoration of wild-type p53 activity in p53-null HL-60 cells confers multidrug sensitivity
    Ju, JF
    Banerjee, D
    Lenz, HJ
    Danenberg, KD
    Schmittgen, TC
    Spears, CP
    Schonthal, AH
    Manno, DJ
    Hochhauser, D
    Bertino, JR
    Danenberg, PV
    CLINICAL CANCER RESEARCH, 1998, 4 (05) : 1315 - 1322
  • [27] Radiosensitivity of human breast cancer cells transduced with wild-type p53 gene is influenced by the p53 status of parental cells
    Maeda, T
    Matsubara, H
    Koide, Y
    Sugaya, M
    Miyazawa, Y
    Tasaki, K
    Isono, K
    Ochiai, T
    Sakiyama, S
    Tagawa, M
    ANTICANCER RESEARCH, 2000, 20 (2A) : 869 - 874
  • [28] EXPRESSION OF WILD-TYPE P53 IN HUMAN A673 CELLS SUPPRESSES TUMORIGENICITY BUT NOT GROWTH-RATE
    CHEN, YM
    CHEN, PL
    ARNAIZ, N
    GOODRICH, D
    LEE, WH
    ONCOGENE, 1991, 6 (10) : 1799 - 1805
  • [29] Activities of wild-type and mutant p53
    Vousden, Karen H.
    CANCER RESEARCH, 2013, 73
  • [30] Flavonoids activate wild-type p53
    Plaumann, B
    Fritsche, M
    Rimpler, H
    Brandner, G
    Hess, RD
    ONCOGENE, 1996, 13 (08) : 1605 - 1614